[HTML][HTML] Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective

W Yu, JD Cheng - Frontiers in pharmacology, 2020 - frontiersin.org
Uric acid (UA) is the end product of purine nucleotide metabolism in the human body.
Hyperuricemia is an abnormally high level of UA in the blood and may result in arthritis and …

Serum uric acid and the risk of cardiovascular and renal disease

C Borghi, EA Rosei, T Bardin, J Dawson… - Journal of …, 2015 - journals.lww.com
Substantial evidence suggests that chronic hyperuricemia is an independent risk factor for
hypertension, metabolic syndrome, chronic kidney disease (CKD) and cardiovascular …

Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid

A Tedeschi, P Agostoni, B Pezzuto… - European journal of …, 2020 - academic.oup.com
Despite improvements in pharmacotherapy, morbidity and mortality rates in community-
based populations with chronic heart failure still remain high. The increase in medical …

Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF

K McDowell, P Welsh, KF Docherty… - European Journal of …, 2022 - Wiley Online Library
Aims Blood uric acid (UA) levels are frequently elevated in patients with heart failure and
reduced ejection fraction (HFrEF), may lead to gout and are associated with worse …

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial

W Doehner, SD Anker, J Butler, F Zannad… - European Heart …, 2022 - academic.oup.com
Background The sodium-glucose cotransporter-2 inhibitor empagliflozin decreases the risk
of cardiovascular death or hospitalization for heart failure (HF) in patients with HF with …

Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study

ML Muiesan, M Salvetti, A Virdis, S Masi… - Journal of …, 2021 - journals.lww.com
Objective: To assess the prognostic cut-off values of serum uric acid (SUA) in predicting fatal
and morbid heart failure in a large Italian cohort in the frame of the Working Group on Uric …

Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond

W Yu, D Xie, T Yamamoto, H Koyama… - Reviews in Endocrine and …, 2023 - Springer
Hyperuricemia is a metabolic disease caused by purine nucleotide metabolism disorder.
The prevalence of hyperuricemia is increasing worldwide, with a growing trend in the …

Prevalence of hyperuricemia in patients with acute heart failure with either reduced or preserved ejection fraction

A Palazzuoli, G Ruocco, O De Vivo, R Nuti… - The American Journal of …, 2017 - Elsevier
The relation between uric acid (UA) and heart failure has been described; however, there is
little detail concerning acute heart failure (AHF) in patients with reduced versus preserved …

Joint association of hyperuricemia and chronic kidney disease with mortality in patients with chronic heart failure

C Wang, H Che, Y Zhou, R Wang, D Zhu… - Frontiers in …, 2023 - frontiersin.org
Background The joint association of hyperuricemia and chronic kidney disease (CKD) with
mortality in patients with chronic heart failure (CHF) is not conclusive. Methods This …

Prognostic value of serum uric acid in patients with acute heart failure: A meta-analysis

G Huang, J Qin, X Deng, G Luo, D Yu, M Zhang… - Medicine, 2019 - journals.lww.com
Background: Conflicting results have been reported on the prognostic significance of serum
uric acid (SUA) in patients with acute heart failure (AHF). This meta-analysis aimed to …